State-of-the-Art Symposium Past Meetings

2012 ASH®State-of-the-Art Symposium

The 2012 State-of-the-Art Symposium (SAS) took place on September 28-29 in Chicago, IL, and on October 12-13 in Los Angeles, CA.

Both SAS meetings featured leading hematology experts who discussed recent advances in hematologic malignancies, with a special focus on thrombosis.

Program Co-Chairs

Nancy Bartlett, MD
Washington University

Thomas Ortel, MD, PhD
Duke University

2012 Program Topics

  • Thrombopoietic Agents for Idiopathic Thrombocytopenia
  • American College of Chest Physicians (ACCP) Antithrombotic Guidelines with a Focus on Perioperative Management of Anticoagulant Therapy
  • Thrombosis in Cancer - Review of Current ASCO and NCCN Treatment Guidelines
  • Myelodysplastic Syndromes - The Role of Stem Cell Transplant in the Era of Hypomethylating Agents
  • Myeloid Leukemia - Management of Older Patients
  • Diffuse Large B-Cell Lymphoma - Should Cell of Origin and Molecular Characteristics Guide Therapy?
  • Central Nervous System Lymphoma - Treatment and Prevention
  • Follicular Lymphoma - Who, When, and How to Treat?
  • Mantle Cell Lymphoma (MCL) - Where Do New Agents Fit in the Management of MCL?
  • T-Cell Lymphoma - Current Approaches and New Agents
  • Hodgkin Lymphoma - Out with the Old (Radiation Therapy), In with the New (Brentuximab Vedotin)
  • Chronic Lymphocytic Leukemia (CLL) - Frontline and Salvage Therapy for High Risk CLL

back to top